Research coauthored by RTI Health Solutions researchers will be presented at the National Comprehensive Cancer Network (NCCN) 2022 Annual Conference.
Spira A, Liao L, Zhou X, Sherif B, Chen L, Ungar D, Yu E, Radford J, Hamadani M. Health-related quality of life, symptoms, and tolerability of Loncastuximab Tesirine in older versus younger patients with relapsed/refractory diffuse Large b-cell lymphoma treated in a phase 2 clinical trial (LOTIS-2). Poster
